Affordable and accessible medicines for the entire world

Trek Therapeutics is a for-profit company, organized as a public benefit corporation.  Its mission is to develop medicines to treat infectious diseases and commercialize them for global populations. The company’s founders have collectively participated in developing seven approved antiviral drugs. Our objective is to profitably develop safe, novel medicines for infectious diseases at affordable and accessible prices.
Latest News: Sep 15, 2016 – Interim results from Trek Therapeutics’ Phase 2 study show triple combination therapy achieves 100% SVR4 in genotype 4 HCV patients